High density lipoprotein against organ dysfunction following haemorrhagic shock
US6998388B1 · kind B1 · utility
4Cited by
1References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 16, 2000 |
| Grant date | Feb 14, 2006 |
| Priority date | — |
| Expiry date | Aug 9, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P39/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Use of high density lipoprotein and/or derivatives in the manufacture of a medicament for the prevention or treatment of organ dysfunction following ischaemia and reperfusion injury. In particular, the medicament may be for the treatment of end stage organ injury or failure.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.